OWINGS MILLS, Md., March 10, 2014 /PRNewswire/ -- Medifast,
Inc. (NYSE: MED), a leading United
States manufacturer and provider of portion-controlled meal
replacement products and programs, announced today that it will
expand its international presence by launching in Canada in the first quarter of 2014.
Initially, this expansion will take place through Medifast Direct,
the company's e-commerce sales channel, and Medifast Medical
Providers, a network of health care providers who, where available,
will offer Medifast's program and products.
"Expanding into Canada is a
major step in reaching new customers and growing the Medifast brand
globally," said Michael MacDonald,
Chairman and CEO of Medifast. "We are particularly excited to
establish relationships with Canadian consumers as well as health
care providers who wish to help individuals reach and maintain
weight-loss and weight-management goals using the Medifast
plan."
At launch, the program will include a variety of 11 Medifast
Meal Replacement foods with plans to expand the line over time.
Medifast will offer its 5 & 2 & 2 Plan™ through the
Canadian e-commerce site, MedifastNow.ca. A Quick Start Guide will
be provided with each initial order as the program is introduced
into the Canadian market. Additional support from Medifast's
Nutrition Support team and Client Solutions Center will also be
available. Health care providers who would like to learn more can
visit MedifastMD.ca.
MED-G
About Medifast:
Medifast (NYSE: MED) is the leading easy-to-use,
portion-controlled weight-loss program in the United States. Medifast was founded
in 1980 and is located in Owings Mills, Maryland. For
more information, log onto www.MedifastNow.com.
Forward-Looking Statements
Statements contained in this press release that are not purely
historical, such as the timing of the expansion and the number of
products that will be included at launch, are forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934 and the
Private Securities Litigation Reform Act of 1995. Such
forward-looking statements only speak as of the date of this press
release. Statements made in this press release that are
forward-looking in nature may involve risks and uncertainties.
Accordingly, readers are cautioned that any such forward-looking
statements are not guarantees and are subject to certain risks,
uncertainties and assumptions that are difficult to predict,
including, without limitation, general economic conditions and the
timing for receipt of required regulatory approvals for all of the
products at launch. Although Medifast believes that the
expectations reflected in such forward-looking statements are
reasonable as of the date made, readers should not place undue
reliance on such forward-looking statements. Medifast
undertakes no obligations to update publicly or otherwise revise
any forward-looking statements, except as may be required by
law.
SOURCE Medifast, Inc.